Company profile: Paragonix Technologies
1.1 - Company Overview
Company description
- Provider of organ preservation and transport systems for heart, lung, and liver transplantation, including FDA-cleared SherpaPak Cardiac Transport System and LUNGguard, LIVERguard for static hypothermic liver preservation, and BAROguard with automated pressure regulation, plus a digital app for real-time location and temperature tracking and 24/7 clinical support for procurement and organ delivery.
Products and services
- Paragonix LIVERguard: A device intended for the static hypothermic preservation of livers during transportation, designed to prevent physical and thermal trauma
- Paragonix LUNGguard: An FDA-cleared device for lung transportation, offering a sterile, controlled environment that protects donor lungs from physical and thermal damage
- Paragonix SherpaPak Cardiac Transport System: An FDA-cleared device for heart transportation, delivering a sterile, controlled environment to minimize post-transplant complications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Paragonix Technologies
Essential Pharma
HQ: United States
Website
- Description: Provider of new tools for medical researchers and manufacturers to bring performance, convenience, and control to the advancement of basic research and drug discovery, supporting the preservation and growth of human systems from the cell to the entire organ. Based in Ewing, NJ.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Essential Pharma company profile →
Quell Therapeutics
HQ: United Kingdom
Website
- Description: Provider of engineered regulatory T cell (Treg) therapies for solid organ transplant and autoimmune diseases. Develops QEL-001 to prevent liver transplant rejection without lifelong immunosuppression and, with AstraZeneca, engineered Treg therapies for Type 1 Diabetes and Inflammatory Bowel Disease. Offers a modular platform using proprietary technologies to enhance Tregs, target specific antigens, and direct them to specific body targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quell Therapeutics company profile →
Lifeline Scientific
HQ: United States
Website
- Description: Provider of medical technology products and services for cell, tissue, and organ transplantation in the U.S. and internationally, including the LifePort Kidney Transporter for kidney preservation, evaluation, and transport, the LifePort Liver Transporter, and T3 (Tissue Testing Technologies), a cryobiology lab developing preservation and transport methods for transplantation and other biomedical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifeline Scientific company profile →
Vascular Perfusion Solutions
HQ: United States
Website
- Description: Provider of medical devices to preserve and resuscitate vascularized organs, notably the VP.S ENCORE hypothermic machine perfusion system that extends organ viability for transplantation using a nutrient-rich solution instead of ice. Compact and carry-on sized, it includes a single-use component, operates in various environments, and enables reliable organ transport by ground or aircraft without special vehicles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Perfusion Solutions company profile →
OrganOx
HQ: United Kingdom
Website
- Description: Provider of normothermic machine perfusion technology for donor livers via OrganOx metra, enabling functional assessment and preservation for up to 24 hours. Offerings support evaluation of liver function prior to transplantation, provide more flexible transplant logistics and surgery scheduling, and support complex or lengthy surgeries by extending preservation time.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OrganOx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Paragonix Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Paragonix Technologies
2.2 - Growth funds investing in similar companies to Paragonix Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Paragonix Technologies
4.2 - Public trading comparable groups for Paragonix Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →